These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 39201281)

  • 1. Liquid Biopsy in the Clinical Management of Cancers.
    Ho HY; Chung KK; Kan CM; Wong SC
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking the future of cancer diagnosis - promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer.
    Reina C; Šabanović B; Lazzari C; Gregorc V; Heeschen C
    Transl Res; 2024 Oct; 272():41-53. PubMed ID: 38838851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
    Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
    Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing extracellular vesicles using liquid biopsy for cancer diagnosis and monitoring: highlights from AACR Annual Meeting 2024.
    Su X; Shan Z; Duan S
    J Hematol Oncol; 2024 Jul; 17(1):55. PubMed ID: 39075488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers.
    Chung J; Xiao S; Gao Y; Soung YH
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy and Lung Cancer.
    Pisapia P; Malapelle U; Troncone G
    Acta Cytol; 2019; 63(6):489-496. PubMed ID: 30566947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
    Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
    Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Profiling of Liquid Biopsies for Precision Oncology.
    Gonzalez-Kozlova EE
    Adv Exp Med Biol; 2022; 1361():235-247. PubMed ID: 35230692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative Review.
    Krebs MG; Malapelle U; André F; Paz-Ares L; Schuler M; Thomas DM; Vainer G; Yoshino T; Rolfo C
    JAMA Oncol; 2022 Dec; 8(12):1830-1839. PubMed ID: 36264554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy: paving a new avenue for cancer research.
    Kurma K; Eslami-S Z; Alix-Panabières C; Cayrefourcq L
    Cell Adh Migr; 2024 Dec; 18(1):1-26. PubMed ID: 39219215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.
    Onidani K; Shoji H; Kakizaki T; Yoshimoto S; Okaya S; Miura N; Sekikawa S; Furuta K; Lim CT; Shibahara T; Boku N; Kato K; Honda K
    Cancer Sci; 2019 Aug; 110(8):2590-2599. PubMed ID: 31169336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Circulating Tumor DNA in Lymphoma Patients.
    Bruscaggin A; Pini K; Rossi D
    Methods Mol Biol; 2025; 2865():475-490. PubMed ID: 39424738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining Cancer Management Using Integrated Liquid Biopsy.
    Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
    Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine.
    Bao Y; Zhang D; Guo H; Ma W
    Cancer Sci; 2024 Apr; 115(4):1060-1072. PubMed ID: 38308498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
    Rossi G; Ignatiadis M
    Cancer Res; 2019 Jun; 79(11):2798-2804. PubMed ID: 31109952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.